Pregabalin for the Treatment of Pain After Posterior Spinal Fusions

NCT01366196 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

86

Enrollment

OTHER

Sponsor class

Conditions

Lumbar Spinal Fusions

Interventions

DRUG: Pregabalin 150 mg
DRUG: Placebo

Sponsor

Hospital for Special Surgery, New York